HKTV (01137.HK) reportedly in talks for leasing aTV channel
Asia Television Limited (aTV) issued a statement last night confirming the removal of Liu King-bun (雷競斌) as the executive director of the company, and appointed the senior vice president as the executive director in place of him. According to market sources, the reason for Lui's removal is because he strongly opposed to aTV's controlling shareholder Wong Ching's plan to lease the aTV channel to HKTV (01137.HK) +0.130 (4.422%) .
It is reported that HKTV's chairman Ricky Wong and Wong Ching are in talks regarding the lease of the TV channel. Spurred by the news, HKTV's share price once surged over 8% to $3.19.
Share Repurchase Program is always good. Specially NVO. For NOV with $15 billion annual sales with ZERO debt! Show me one other pharma company has that? none. That is why NVO commands premium price and with all that windfall cash flow, they repurchase shares and increase div payout every year.
You give compelling reasons for HKTV potential but it does not reflect on the price of stock nor shares of HKTV. If your thesis is correct on HKTV, the volume would go up on a daily trading days, not necessary the share price. The volume on HKTV trading has been very miserable. You would think they would accumulate at this low price but I dont see it based on volume traded per day. So no one is acculumation or stock price going up anytime soon.
The HKTV stock price will be in $9 or over $10 this summer when it gets close to launch. I have hugh position on HKTV. I am willing to hold another year to see if I will live in Penthouse or Odd house.
What are u talking about? The NIH and EASD found no evidence of pancreatic cancer. Do you know how long it takes to get pancreatic cancer? Do you know? You probably don't know. Well I will tell you. It takes 15 to 20 years to develop pancreatic cancer. The GLP-1 and DPP4 only been in the market for less than 10 years. Don't post something that is false.
Yes, 6 new products lauch in the next 10 years. NVO will continue to go up in the average of 20% a year for the next 10 years. Two things working for NVO. One is global epidemic of type 2 diabetes and Second is 6 products launch. NVO will continue to have strong diabetes position in to next century and Competitive advantage in key segment of diabetes market share. Dont forget about their Bio-Pharn division, the revenue will bringing in more revenues to NVO bottom line. So, Yes! Buy More!!! The safest and high return play with NVO for the next 10 years.
Its more clearity with HKTV now. I always believed content is more valuable these days with more distribution options. Good examples are Disney, Warner Brothers, with ABC, CBS, NBC and FOX developing content to be distrubited into their own channels. HKTV content value is still unknown. How far their distributing their content, not only to HK market but China, Taiwan and all of asia and international markets? More programing content they have, more HK value goes up!
Now we know how they will distribute their contents, we could see HKTV stock price going up more and more.